NCT06239402View on ClinicalTrials.gov

Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease

CompletedOBSERVATIONAL
Enrollment

394

Participants

Timeline

Start Date

July 28, 2020

Primary Completion Date

July 28, 2024

Study Completion Date

July 28, 2024

Conditions
Atrial Fibrillation
Interventions
OTHER

Observation

Observation of mortality, haemorrhagic and ischemic events in the studied population

Trial Locations (1)

Unknown

Istituti Clinici Scientifici Maugeri, Milan

All Listed Sponsors
collaborator

Società Italiana Cardiologia Ospedalità Accreditata (SICOA)

UNKNOWN

lead

Istituti Clinici Scientifici Maugeri SpA

OTHER

NCT06239402 - Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease | Biotech Hunter | Biotech Hunter